Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandre P Zavascki

Showing results (61-70 of 66) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 66 results.
Clinical Pharmacology and Therapeutics|June 17, 2025
Population Pharmacokinetic/Toxicodynamic Model for Polymyxin B in Critically Ill Patients to Identify the Risk of NephrotoxicityPatrick O Hanafin, Ramya Mahadevan, Gauri G Rao, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 2, 2026
Population pharmacokinetics of polymyxin B: an individual participant data meta-analysisSaikumar Matcha, Gauri G Rao, Patrick O Hanafin, et al.
The European Respiratory Journal|July 10, 2021
Convalescent plasma for COVID-19 in hospitalised patients: an open-label, randomised clinical trialLeo Sekine, Beatriz Arns, Bruna R Fabro, et al.
Diagnostic Microbiology and Infectious Disease|September 14, 2015
The changing epidemiology of Acinetobacter spp. producing OXA carbapenemases causing bloodstream infections in Brazil: a BrasNet reportAna Tereza R Vasconcelos, Afonso L Barth, Alexandre P Zavascki, et al.
Critical Care (London, England)|December 19, 2024
Seven versus 14 days of antimicrobial therapy for severe multidrug-resistant Gram-negative bacterial infections in intensive care unit patients (OPTIMISE): a randomised, open-label, non-inferiority clinical trialBeatriz Arns, Andre C Kalil, Guilherme G L Sorio, et al.
Lancet Regional Health. Americas|February 17, 2025
World Health Organization priority antimicrobial resistance in <i>Enterobacterales, Acinetobacter baumannii, Pseudomonas aeruginosa, Staphylococcus aureus</i> and <i>Enterococcus faecium</i> healthcare-associated bloodstream infections in Brazil (ASCENSION): a prospective, multicentre, observational studyLaura C Antochevis, Camila M Wilhelm, Beatriz Arns, et al.
Pageof 7

Showing results (61-70 of 66) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 66 results.
Clinical Pharmacology and Therapeutics|June 17, 2025
Population Pharmacokinetic/Toxicodynamic Model for Polymyxin B in Critically Ill Patients to Identify the Risk of NephrotoxicityPatrick O Hanafin, Ramya Mahadevan, Gauri G Rao, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 2, 2026
Population pharmacokinetics of polymyxin B: an individual participant data meta-analysisSaikumar Matcha, Gauri G Rao, Patrick O Hanafin, et al.
The European Respiratory Journal|July 10, 2021
Convalescent plasma for COVID-19 in hospitalised patients: an open-label, randomised clinical trialLeo Sekine, Beatriz Arns, Bruna R Fabro, et al.
Diagnostic Microbiology and Infectious Disease|September 14, 2015
The changing epidemiology of Acinetobacter spp. producing OXA carbapenemases causing bloodstream infections in Brazil: a BrasNet reportAna Tereza R Vasconcelos, Afonso L Barth, Alexandre P Zavascki, et al.
Critical Care (London, England)|December 19, 2024
Seven versus 14 days of antimicrobial therapy for severe multidrug-resistant Gram-negative bacterial infections in intensive care unit patients (OPTIMISE): a randomised, open-label, non-inferiority clinical trialBeatriz Arns, Andre C Kalil, Guilherme G L Sorio, et al.
Lancet Regional Health. Americas|February 17, 2025
World Health Organization priority antimicrobial resistance in <i>Enterobacterales, Acinetobacter baumannii, Pseudomonas aeruginosa, Staphylococcus aureus</i> and <i>Enterococcus faecium</i> healthcare-associated bloodstream infections in Brazil (ASCENSION): a prospective, multicentre, observational studyLaura C Antochevis, Camila M Wilhelm, Beatriz Arns, et al.
Pageof 7